Hasegawa M - Search Results

1

Identical tau filaments in subacute sclerosing panencephalitis and chronic traumatic encephalopathy.

Qi C, Hasegawa M, Takao M, Sakai M, Sasaki M, Mizutani M, Akagi A, Iwasaki Y, Miyahara H, Yoshida M, Scheres SHW, Goedert M. Qi C, et al. Among authors: hasegawa m. Acta Neuropathol Commun. 2023 May 5;11(1):74. doi: 10.1186/s40478-023-01565-2. Acta Neuropathol Commun. 2023. PMID: 37143123 Free PMC article.

2

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins.

Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M. Taniguchi S, et al. Among authors: hasegawa m. J Biol Chem. 2005 Mar 4;280(9):7614-23. doi: 10.1074/jbc.M408714200. Epub 2004 Dec 17. J Biol Chem. 2005. PMID: 15611092 Free article.

3

Cysteine misincorporation in bacterially expressed human alpha-synuclein.

Masuda M, Dohmae N, Nonaka T, Oikawa T, Hisanaga S, Goedert M, Hasegawa M. Masuda M, et al. Among authors: hasegawa m. FEBS Lett. 2006 Mar 20;580(7):1775-9. doi: 10.1016/j.febslet.2006.02.032. Epub 2006 Feb 24. FEBS Lett. 2006. PMID: 16513114 Free article.

4

Small molecule inhibitors of alpha-synuclein filament assembly.

Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, Iwatsubo T, Hisanaga S, Goedert M, Hasegawa M. Masuda M, et al. Among authors: hasegawa m. Biochemistry. 2006 May 16;45(19):6085-94. doi: 10.1021/bi0600749. Biochemistry. 2006. PMID: 16681381

5

Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.

Ishii A, Nonaka T, Taniguchi S, Saito T, Arai T, Mann D, Iwatsubo T, Hisanaga S, Goedert M, Hasegawa M. Ishii A, et al. Among authors: hasegawa m. FEBS Lett. 2007 Oct 2;581(24):4711-7. doi: 10.1016/j.febslet.2007.08.067. Epub 2007 Sep 6. FEBS Lett. 2007. PMID: 17868672 Free article.

6

Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies.

Masuda M, Hasegawa M, Nonaka T, Oikawa T, Yonetani M, Yamaguchi Y, Kato K, Hisanaga S, Goedert M. Masuda M, et al. Among authors: hasegawa m. FEBS Lett. 2009 Feb 18;583(4):787-91. doi: 10.1016/j.febslet.2009.01.037. Epub 2009 Feb 4. FEBS Lett. 2009. PMID: 19183551 Free article.

7

[Significance of the TDP-43 deposition in FTLD-U and ALS].

Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H. Hasegawa M, et al. Rinsho Shinkeigaku. 2008 Nov;48(11):994-7. doi: 10.5692/clinicalneurol.48.994. Rinsho Shinkeigaku. 2008. PMID: 19198142 Review. Japanese.

8

Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.

Yamashita M, Nonaka T, Arai T, Kametani F, Buchman VL, Ninkina N, Bachurin SO, Akiyama H, Goedert M, Hasegawa M. Yamashita M, et al. Among authors: hasegawa m. FEBS Lett. 2009 Jul 21;583(14):2419-24. doi: 10.1016/j.febslet.2009.06.042. Epub 2009 Jun 26. FEBS Lett. 2009. PMID: 19560462 Free article.

9

[TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].

Hasegawa M, Nonaka T, Yamashita M, Kametani F, Arai T, Yoshida M, Hashizume Y, Tsuchiya K, Akiyama H. Hasegawa M, et al. Rinsho Shinkeigaku. 2009 Nov;49(11):783-5. doi: 10.5692/clinicalneurol.49.783. Rinsho Shinkeigaku. 2009. PMID: 20030209 Review. Japanese.

10

Molecular analysis and biochemical classification of TDP-43 proteinopathy.

Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao M, Saito Y, Murayama S, Akiyama H, Hasegawa M, Mann DM, Tamaoka A. Tsuji H, et al. Among authors: hasegawa m. Brain. 2012 Nov;135(Pt 11):3380-91. doi: 10.1093/brain/aws230. Epub 2012 Oct 3. Brain. 2012. PMID: 23035040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,137 results

Search Page